CAMBRIUM

cambrium-logo

Cambrium's mission is to trigger the next wave of material innovation by harnessing natureโ€™s protein building blocks. Our platform combines synthetic biology, machine learning and lab automation to create high-performance materials at scale. We fundamentally believe that the ability to align economic and environmental incentives makes biology the most important manufacturing technology of the 21st century. We are accelerating a Cambrian explosion of biomaterials to address the worldโ€™s most pressing problems.

#People #Financial #Website #More

CAMBRIUM

Social Links:

Industry:
Advanced Materials Bioinformatics Biotechnology Machine Learning Robotics

Founded:
2020-08-01

Address:
Berlin, Berlin, Germany

Country:
Germany

Website Url:
http://www.cambrium.bio

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
0

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Global Site Tag Euro IPv6


Current Employees Featured

charlie-cotton_image

Charlie Cotton
Charlie Cotton Co-Founder & CSO @ Cambrium
Co-Founder & CSO
2020-08-01

mitchell-duffy_image

Mitchell Duffy
Mitchell Duffy Chief Executive Officer @ Cambrium
Chief Executive Officer
2020-08-01

Founder


charlie-cotton_image

Charlie Cotton

mitchell-duffy_image

Mitchell Duffy

Investors List

merantix_image

Merantix

Merantix investment in Seed Round - Cambrium

Official Site Inspections

http://www.cambrium.bio Semrush global rank: 5.68 M Semrush visits lastest month: 1.48 K

  • Host name: 198.185.159.145
  • IP address: 198.185.159.145
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "Cambrium"

Cambrium - Crunchbase Company Profile & Funding

Contact Email [email protected] Cambrium's mission is to trigger the next wave of material innovation by harnessing natureโ€™s protein building blocks. Our platform combines synthetic biology, machine learning and lab automation to create โ€ฆSee details»

Cambrium Company Profile 2024: Valuation, Funding & Investors

Information on valuation, funding, cap tables, investors, and executives for Cambrium. Use the PitchBook Platform to explore the full profile.See details»

Cambrium - LinkedIn

Join Cambrium as our Chief of Staff! We're on a mission to transform material innovation by using biology's molecular building blocks to create next-gen solutions for industries like personal care ...See details»

Cambrium - Company Profile - Tracxn

Dec 5, 2024 Cambrium - Provider and developer of protein based biomaterials for skin applications. Raised a total funding of $11.6M over 2 rounds from 7 investors. Cambrium has โ€ฆSee details»

Synthetic Biology Start-Up Cambrium Raises $11.6 โ€ฆ

Nov 9, 2023 Synthetic biology start-up Cambrium secured $8.5 million, bringing total seed funding to $11.6 million, to fuel the commercialization of a new class of designer proteins that scale sustainably.See details»

Cambrium Secures โ‚ฌ8 Million in Seed Funding to - GlobeNewswire

BERLIN, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Synthetic biology startup Cambrium announces โ‚ฌ8 Million in Seed financing, led by Essential Capital, along with SNR, Valor Equity Partners, โ€ฆSee details»

Cambrium (Cambrium GmbH) - Startbase

Official Website: cambrium.bio; On Social Media: Legal Entity: Cambrium GmbH Location: Berlin Overview Company Funding Product Team News Is this your company? Profile is not claimed โ€ฆSee details»

Innovation in Bloom: Cambriumโ€™s โ‚ฌ8 Million Seed to Sow

Oct 31, 2023 Cambrium, a synthetic biology startup based in the German capital, announced today that it has secured โ‚ฌ8 million in seed financing.The funding round was led by Essential โ€ฆSee details»

Cambrium | EU-Startups

Cambrium's mission is to trigger the next wave of material innovation by harnessing natureโ€™s protein building blocks. It develops proteins to create better materials.See details»

AI For Protein Design Fuels Collaboration Between โ€ฆ

Apr 18, 2023 Cambrium, a leading German start-up focused on applying generative AI to protein design and synthesis, has successfully completed its collaboration with Ginkgo Bioworks, a company building the ...See details»

Careers โ€” Cambrium

On founding Cambrium, our core mission, and the promise of biologyโ€™s molecular building blocks.See details»

Cambrium (@cambrium_bio) โ€ข Instagram photos and videos

Recently we shared our work with The Vegan Society, the oldest vegan organization in the world, and are now proud to be holders of the Vegan Trademark. This certification confirms the start โ€ฆSee details»

Cambrium | CipherBio

Explore Cambrium's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»

Mitchell Duffy: Novel Materials, Novel Functionalities - Swisspreneur

May 23, 2022 About Mitchell Duffy: Mitchell Duffy is the CEO and co-founder at Cambrium, a next-generation materials company utilizing the molecular programmability of proteins to re โ€ฆSee details»

Technology โ€” Cambrium

Our molecular design technology is igniting a Cambrian explosion of bio-based materials. With an ever-growing nebula of high-performance molecules, we transform every day products in โ€ฆSee details»

Cambrium and Ginkgo Bioworks Complete Successful โ€ฆ

BERLIN and BOSTON, April 18, 2023 /PRNewswire/ -- Cambrium, a leading German start-up focused on the application of generative AI to protein design and synthesis, and Ginkgo โ€ฆSee details»

Cambium Bio Limited Annual Report FY2024 - Cambium Bio

Aug 30, 2024 Cambium Bio is a patient-focused, clinical-stage, regenerative medicine company developing a pioneering platform in ophthalmology and tissue regeneration. Cambium Bio โ€ฆSee details»

Cambium Bio | Regenerative Medicine Company

Cambium Bio is a patient-focused, clinical-stage, regenerative medicine company developing a pioneering platform in ophthalmology and tissue regeneration. Investors and Media. Investors โ€ฆSee details»

Cambium Bio | Regenerative Medicine Company

Cambium Bio is a patient-focused, clinical-stage, regenerative medicine company developing a pioneering platform in ophthalmology and tissue regeneration. At a glance Cambium Bio โ€ฆSee details»

linkstock.net © 2022. All rights reserved